Fig. 4
From: The correlation between HTA recommendations and reimbursement status of orphan drugs in Europe
Share (%) of all assessed orphan drugs that are reimbursed, by country. Source: Authors based on information from the websites of the eight HTA agencies. Note: Countries where there are special criteria for orphan drugs in the reimbursement decision process are marked in black